Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 21 | 2018 | 336 | 2.620 |
Why?
|
| Migraine Disorders | 3 | 2016 | 66 | 0.660 |
Why?
|
| Population Surveillance | 2 | 2013 | 285 | 0.420 |
Why?
|
| Stroke | 2 | 2015 | 2163 | 0.410 |
Why?
|
| Attitude to Health | 1 | 2009 | 403 | 0.270 |
Why?
|
| South Carolina | 8 | 2018 | 2752 | 0.270 |
Why?
|
| Caregivers | 1 | 2009 | 365 | 0.260 |
Why?
|
| Comorbidity | 5 | 2016 | 1426 | 0.240 |
Why?
|
| Adolescent | 15 | 2016 | 8912 | 0.230 |
Why?
|
| Infant | 7 | 2016 | 2891 | 0.230 |
Why?
|
| Child, Preschool | 7 | 2016 | 3187 | 0.220 |
Why?
|
| Child | 10 | 2016 | 6405 | 0.210 |
Why?
|
| Male | 26 | 2018 | 37321 | 0.200 |
Why?
|
| Infant, Newborn | 5 | 2015 | 2455 | 0.200 |
Why?
|
| Female | 24 | 2018 | 38074 | 0.190 |
Why?
|
| Adult | 26 | 2018 | 21403 | 0.190 |
Why?
|
| Health Behavior | 2 | 2016 | 458 | 0.170 |
Why?
|
| Cause of Death | 3 | 2015 | 241 | 0.160 |
Why?
|
| Humans | 33 | 2018 | 68618 | 0.150 |
Why?
|
| Urban Population | 2 | 2016 | 255 | 0.150 |
Why?
|
| Fractures, Bone | 2 | 2016 | 132 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2018 | 7277 | 0.150 |
Why?
|
| Aged | 11 | 2018 | 14862 | 0.140 |
Why?
|
| Risk Factors | 6 | 2018 | 5731 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2018 | 1553 | 0.140 |
Why?
|
| Middle Aged | 16 | 2018 | 21147 | 0.140 |
Why?
|
| Risk | 2 | 2016 | 563 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 955 | 0.140 |
Why?
|
| Seizures | 3 | 2013 | 279 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 50 | 0.130 |
Why?
|
| Patient Transfer | 1 | 2016 | 86 | 0.130 |
Why?
|
| Rural Population | 2 | 2016 | 398 | 0.130 |
Why?
|
| Status Epilepticus | 1 | 2016 | 74 | 0.130 |
Why?
|
| Patient Advocacy | 1 | 2015 | 40 | 0.130 |
Why?
|
| Population | 1 | 2015 | 11 | 0.130 |
Why?
|
| Mortality, Premature | 1 | 2014 | 7 | 0.120 |
Why?
|
| Age of Onset | 1 | 2015 | 188 | 0.120 |
Why?
|
| Age Factors | 4 | 2016 | 1864 | 0.120 |
Why?
|
| Young Adult | 6 | 2016 | 5717 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2015 | 186 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 807 | 0.110 |
Why?
|
| Incidence | 2 | 2015 | 1603 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 142 | 0.110 |
Why?
|
| Prevalence | 2 | 2015 | 1619 | 0.100 |
Why?
|
| International Classification of Diseases | 2 | 2009 | 85 | 0.100 |
Why?
|
| Health Status | 1 | 2015 | 429 | 0.100 |
Why?
|
| Health Surveys | 1 | 2013 | 489 | 0.100 |
Why?
|
| Phenobarbital | 2 | 1989 | 25 | 0.100 |
Why?
|
| Self Efficacy | 2 | 2009 | 199 | 0.100 |
Why?
|
| Social Support | 2 | 2015 | 423 | 0.090 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2009 | 4 | 0.090 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 30 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2015 | 2358 | 0.090 |
Why?
|
| Chromatography | 1 | 1989 | 47 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2009 | 1851 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2015 | 2007 | 0.080 |
Why?
|
| Anticonvulsants | 4 | 2004 | 223 | 0.080 |
Why?
|
| Hospitalization | 2 | 2016 | 978 | 0.080 |
Why?
|
| Personality Inventory | 1 | 2009 | 197 | 0.080 |
Why?
|
| Employment | 1 | 2009 | 154 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2013 | 659 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 2800 | 0.080 |
Why?
|
| Self Concept | 1 | 2008 | 132 | 0.070 |
Why?
|
| Self Care | 1 | 2009 | 253 | 0.070 |
Why?
|
| Brain Injuries | 2 | 2009 | 268 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 1420 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 1985 | 31 | 0.060 |
Why?
|
| Heart Block | 1 | 2004 | 49 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3259 | 0.060 |
Why?
|
| Vagus Nerve | 1 | 2004 | 90 | 0.060 |
Why?
|
| Quality of Life | 2 | 2009 | 1515 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2004 | 113 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 581 | 0.060 |
Why?
|
| Electric Stimulation Therapy | 1 | 2004 | 147 | 0.050 |
Why?
|
| Electroencephalography | 5 | 1998 | 418 | 0.050 |
Why?
|
| Death, Sudden | 2 | 1997 | 24 | 0.050 |
Why?
|
| Cerebral Cortex | 5 | 1998 | 415 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 1980 | 47 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 1976 | 107 | 0.040 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 1985 | 138 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1998 | 100 | 0.040 |
Why?
|
| Patient Compliance | 1 | 1980 | 402 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 1998 | 219 | 0.040 |
Why?
|
| Psychological Tests | 1 | 1976 | 96 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.030 |
Why?
|
| Hydrocephalus | 2 | 1974 | 40 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 792 | 0.030 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1974 | 6 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 141 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2015 | 201 | 0.030 |
Why?
|
| Military Medicine | 1 | 1974 | 53 | 0.030 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2015 | 199 | 0.030 |
Why?
|
| Synaptic Membranes | 1 | 1973 | 8 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 425 | 0.030 |
Why?
|
| Prognosis | 3 | 2009 | 2093 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Ethosuximide | 2 | 1980 | 2 | 0.020 |
Why?
|
| Prolactin | 3 | 1985 | 61 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 711 | 0.020 |
Why?
|
| Carbamazepine | 2 | 1980 | 108 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4848 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2008 | 73 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2008 | 239 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2009 | 294 | 0.020 |
Why?
|
| Hydrocortisone | 2 | 1985 | 291 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1054 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2009 | 621 | 0.020 |
Why?
|
| Libido | 1 | 1985 | 7 | 0.020 |
Why?
|
| Apnea | 1 | 1985 | 16 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 445 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 1985 | 22 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1985 | 78 | 0.010 |
Why?
|
| Cats | 1 | 1985 | 292 | 0.010 |
Why?
|
| Limbic System | 1 | 1985 | 106 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 98 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1985 | 85 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1974 | 219 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 223 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 42 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 249 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1985 | 324 | 0.010 |
Why?
|
| Synapses | 3 | 1974 | 222 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 2 | 1974 | 290 | 0.010 |
Why?
|
| Primidone | 1 | 1980 | 1 | 0.010 |
Why?
|
| Phenytoin | 1 | 1980 | 27 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1974 | 36 | 0.010 |
Why?
|
| Temporal Lobe | 2 | 1976 | 125 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1998 | 61 | 0.010 |
Why?
|
| Frontal Lobe | 2 | 1976 | 156 | 0.010 |
Why?
|
| Subcellular Fractions | 2 | 1974 | 92 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1985 | 2550 | 0.010 |
Why?
|
| Pneumoencephalography | 2 | 1974 | 3 | 0.010 |
Why?
|
| Cerebral Ventriculography | 2 | 1974 | 4 | 0.010 |
Why?
|
| Drowning | 1 | 1997 | 5 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 579 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1985 | 1140 | 0.010 |
Why?
|
| Placebos | 1 | 1997 | 195 | 0.010 |
Why?
|
| Autopsy | 2 | 1974 | 56 | 0.010 |
Why?
|
| Triazines | 1 | 1997 | 48 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1974 | 351 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1976 | 59 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1998 | 340 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1998 | 532 | 0.010 |
Why?
|
| Hypertension | 1 | 2004 | 1535 | 0.010 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1974 | 2 | 0.010 |
Why?
|
| Sweat | 1 | 1974 | 5 | 0.010 |
Why?
|
| Lipidoses | 1 | 1974 | 1 | 0.010 |
Why?
|
| Hexosaminidases | 1 | 1974 | 7 | 0.010 |
Why?
|
| Gangliosides | 1 | 1974 | 29 | 0.010 |
Why?
|
| Vietnam | 1 | 1974 | 36 | 0.010 |
Why?
|
| Cerebral Aqueduct | 1 | 1974 | 1 | 0.010 |
Why?
|
| Apraxias | 1 | 1974 | 4 | 0.010 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1974 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1974 | 58 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 1974 | 67 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1974 | 94 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1974 | 186 | 0.010 |
Why?
|
| Neurofibrils | 1 | 1973 | 2 | 0.010 |
Why?
|
| Synaptic Vesicles | 1 | 1973 | 18 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 156 | 0.010 |
Why?
|
| Copper | 1 | 1974 | 149 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1973 | 57 | 0.010 |
Why?
|
| Manometry | 1 | 1974 | 276 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 848 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1973 | 173 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1972 | 36 | 0.010 |
Why?
|
| Dementia | 1 | 1974 | 158 | 0.010 |
Why?
|
| Animals | 3 | 1985 | 20881 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1992 | 286 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 2334 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1983 | 31 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1974 | 272 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1983 | 51 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1983 | 29 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1983 | 49 | 0.000 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1982 | 22 | 0.000 |
Why?
|
| Swine | 2 | 1974 | 672 | 0.000 |
Why?
|
| United States | 1 | 1974 | 7367 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1980 | 48 | 0.000 |
Why?
|
| Half-Life | 1 | 1980 | 96 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1980 | 119 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1980 | 289 | 0.000 |
Why?
|
| Kinetics | 1 | 1980 | 1047 | 0.000 |
Why?
|
| Steam Bath | 1 | 1974 | 1 | 0.000 |
Why?
|
| Penicillamine | 1 | 1974 | 10 | 0.000 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1974 | 11 | 0.000 |
Why?
|
| Electrophoresis, Starch Gel | 1 | 1974 | 2 | 0.000 |
Why?
|
| Membranes | 1 | 1974 | 26 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1974 | 19 | 0.000 |
Why?
|
| Phospholipids | 1 | 1974 | 108 | 0.000 |
Why?
|
| Fetus | 1 | 1974 | 157 | 0.000 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1973 | 24 | 0.000 |
Why?
|
| Solubility | 1 | 1973 | 134 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1973 | 358 | 0.000 |
Why?
|
| Cholesterol | 1 | 1974 | 331 | 0.000 |
Why?
|
| Brain Edema | 1 | 1972 | 50 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1972 | 182 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1972 | 371 | 0.000 |
Why?
|